SCHEMBL24145102

SCHEMBL24145102

COP(=O)(O)OP(=O)(O)OCC1OC(n2cnc3c(N)ncnc32)C2OC(C)(C)OC12

nearest known ligand 0.87

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RX3 P56373 9/20 0.87
▸ P2RX4 Q99571 7/20 0.87
▸ P2RX1 P51575 6/20 0.87
▸ P2RY1 P47900 4/20 0.66
▸ P2RX2 Q9UBL9 4/20 0.66
▸ P2RY2 P41231 2/20 0.66
▸ ALDH1A1 P00352 2/20 0.66
▸ SRC P12931 1/20 0.66
▸ SMN1; SMN2 Q16637 1/20 0.66
▸ PI4KA P42356 1/20 0.65
▸ PI4K2B Q8TCG2 1/20 0.65
▸ PI4K2A Q9BTU6 1/20 0.65
▸ PI4KB Q9UBF8 1/20 0.65
▸ RXFP1 Q9HBX9 1/20 0.65
▸ P2RY12 Q9H244 1/20 0.63
▸ MACROD2 A1Z1Q3 1/20 0.62
▸ SIRT6 Q8N6T7 1/20 0.62
▸ MACROD1 Q9BQ69 1/20 0.62
▸ TRPM2 O94759 1/20 0.62
▸ MEN1 O00255 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23922240 0.93 P2RX3 (0.97) P2RX3P2RX4P2RX1P2RY1P2RX2
SCHEMBL14414863 0.93 P2RX3 (0.97) P2RX3P2RX4P2RX1P2RY1P2RX2
SCHEMBL26361537 0.89 P2RX3 (0.84) P2RX3P2RX4P2RX1P2RY1P2RX2
SCHEMBL22402648 0.89 P2RX3 (0.84) P2RX3P2RX4P2RX1P2RY1P2RX2
SCHEMBL22392998 0.89 P2RX3 (0.84) P2RX3P2RX4P2RX1P2RY1P2RX2
SCHEMBL24205134 0.89 P2RX3 (0.75) P2RX3P2RX4P2RX1P2RY1P2RX2
SCHEMBL3781395 0.86 P2RX3 (0.76) P2RX3P2RX4P2RX1P2RY1P2RY2
SCHEMBL24145215 0.85 P2RX3 (0.71) P2RX3P2RX4P2RX1P2RY1P2RX2
SCHEMBL24205136 0.85 P2RX3 (0.69) P2RX3P2RX4P2RX1P2RY1P2RX2
SCHEMBL22652873 0.85 P2RY1 (0.91) P2RX3P2RX4P2RX1P2RY1P2RX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11773131-B2 Compositions and methods of modulating the immune response by activating alpha protein kinase 1 SHANGHAI YAO YUAN BIOTECHNOLOGY CO., LTD. (CN) 2023-10-03 — — US disclosed
US-20210403501-A1 COMPOSITIONS AND METHODS OF MODULATING THE IMMUNE RESPONSE BY ACTIVATING ALPHA PROTEIN KINASE 1 SHANGHAI XINQI WU FILM AND TELEVISION INVESTMENT CO., LTD. (CN) 2021-12-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11773131-B2 Compositions and methods of modulating the immune response by activating alpha protein kinase 1 PHKA1, PHKA2, PRKCA P2RX3 1233/4885P2RX4 2015/4885P2RX1 885/4885
US-20210403501-A1 COMPOSITIONS AND METHODS OF MODULATING THE IMMUNE RESPONSE BY ACTIVATING ALPHA PROTEIN KINASE 1 PHKA1, PHKA2, PRKCA P2RX3 1233/4885P2RX4 2015/4885P2RX1 885/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback